Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection

Susanna K. Elledge, View ORCID ProfileXin X. Zhou, View ORCID ProfileJames R. Byrnes, Alexander J. Martinko, View ORCID ProfileIrene Lui, Katarina Pance, View ORCID ProfileShion A. Lim, View ORCID ProfileJeff E. Glasgow, Anum A. Glasgow, Keirstinne Turcios, Nikita Iyer, Leonel Torres, Michael J. Peluso, Timothy J. Henrich, Taia T. Wang, Cristina M. Tato, View ORCID ProfileKevin K. Leung, Bryan Greenhouse, James A. Wells
doi: https://doi.org/10.1101/2020.08.17.20176925
Susanna K. Elledge
1Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xin X. Zhou
1Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xin X. Zhou
James R. Byrnes
1Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James R. Byrnes
Alexander J. Martinko
2Soteria Biotherapeutics, San Francisco, California, 94107, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene Lui
1Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Irene Lui
Katarina Pance
1Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shion A. Lim
1Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shion A. Lim
Jeff E. Glasgow
1Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeff E. Glasgow
Anum A. Glasgow
3Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keirstinne Turcios
4Department of Medicine, University of California San Francisco, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikita Iyer
4Department of Medicine, University of California San Francisco, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonel Torres
4Department of Medicine, University of California San Francisco, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Peluso
4Department of Medicine, University of California San Francisco, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy J. Henrich
4Department of Medicine, University of California San Francisco, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taia T. Wang
5Chan Zuckerberg Biohub, San Francisco, California, 94158, USA.
6Departments of Medicine and of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, 94305, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristina M. Tato
5Chan Zuckerberg Biohub, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin K. Leung
1Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kevin K. Leung
Bryan Greenhouse
4Department of Medicine, University of California San Francisco, San Francisco, California, 94158, USA.
5Chan Zuckerberg Biohub, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James A. Wells
1Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, 94158, USA.
5Chan Zuckerberg Biohub, San Francisco, California, 94158, USA.
7Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, 94158, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Jim.Wells@ucsf.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

SUMMARY

Current serology tests for SARS-CoV-2 antibodies mainly take the form of enzyme-linked immunosorbent assays or lateral flow assays, with the former being laborious and the latter being expensive and often lacking sufficient sensitivity and scalability. Here we present the development and validation of a rapid, low-cost solution-based assay to detect antibodies in serum, plasma, whole blood, and saliva, using rationally designed split luciferase antibody biosensors (spLUC). This new assay, which generates quantitative results in as short as 5 minutes, substantially reduces the complexity and improves the scalability of COVID-19 antibody tests for point-of-care and broad population testing.

Competing Interest Statement

S.K.E, X.X.Z., and J.A.W. have filed a provisional patent on the described solution-based antibody detection assay (spLUC). J.E.G., A.A.G., I.L. and X.X.Z. have filed a provisional patent on the ACE2 variants.

Funding Statement

J.A.W. is grateful for funding from the Harry and Dianna Hind Endowed Professorship in Pharmaceutical Sciences and the Chan Zuckerberg Biohub that helped support this work. The National Science Foundation Graduate Research Fellowship Program supported S.K.E (1650113) and I.L (2017244707). Postdoctoral Fellowship support included a National Institutes of Health National Cancer Institute F32 (5F32CA239417 to J.R.B.), a Merck Fellow of the Damon Runyon Cancer Research Foundation (DRG-2297-17 to X.X.Z.), a Merck Postdoctoral Research Fellow from the Helen Hay Whitney Foundation (S.A.L.), and a National Institutes of Health K99/R00 (1K99GM135529 to A.A.G.). The LIINC cohort study was funded by NIH/NIAID 3R01AI141003-03S1 (T.J.H.). T.T.W was supported in part by Fast Grants, CEND COVID Catalyst Fund, the NIH/NIAID (U19AI111825 and R01AI139119) and by the Rockefeller University Center for Clinical and Translational Science Grant # UL1 TR001866. We would like to acknowledge funding from the Chan Zuckerberg Biohub, Rapid Response as well.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All patient samples were obtained using protocols approved by the UCSF, Stanford University, and Rockefeller University Institutional Review Boards and in accordance with the Declaration of Helsinki. Samples were de-identified prior to delivery to the lab where all assays described here were performed. Collection of remnant sera from Kaiser Permanente was approved by the Institutional Review Board of Stanford University (protocol #55718). Influenza virus vaccination samples were from a US cohort enrolled at the Rockefeller University Hospital in New York City in 2012-2013 under a protocol approved by the Institutional Review Board of Rockefeller University (protocol #TWA-0804). Samples from people with seasonal coronavirus infections were collected at the University of Chicago. Samples were de-identified serums of healthcare workers that had respiratory illnesses, were swabbed, and tested positive for common cold coronavirus infections in 2019 (U. Chicago protocol # 09-043-A).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data described in the manuscript is available upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 21, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection
Susanna K. Elledge, Xin X. Zhou, James R. Byrnes, Alexander J. Martinko, Irene Lui, Katarina Pance, Shion A. Lim, Jeff E. Glasgow, Anum A. Glasgow, Keirstinne Turcios, Nikita Iyer, Leonel Torres, Michael J. Peluso, Timothy J. Henrich, Taia T. Wang, Cristina M. Tato, Kevin K. Leung, Bryan Greenhouse, James A. Wells
medRxiv 2020.08.17.20176925; doi: https://doi.org/10.1101/2020.08.17.20176925
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection
Susanna K. Elledge, Xin X. Zhou, James R. Byrnes, Alexander J. Martinko, Irene Lui, Katarina Pance, Shion A. Lim, Jeff E. Glasgow, Anum A. Glasgow, Keirstinne Turcios, Nikita Iyer, Leonel Torres, Michael J. Peluso, Timothy J. Henrich, Taia T. Wang, Cristina M. Tato, Kevin K. Leung, Bryan Greenhouse, James A. Wells
medRxiv 2020.08.17.20176925; doi: https://doi.org/10.1101/2020.08.17.20176925

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (47)
  • Cardiovascular Medicine (416)
  • Dentistry and Oral Medicine (70)
  • Dermatology (49)
  • Emergency Medicine (146)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4875)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (678)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (633)
  • Health Policy (322)
  • Health Systems and Quality Improvement (208)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5362)
  • Intensive Care and Critical Care Medicine (332)
  • Medical Education (94)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (690)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (127)
  • Occupational and Environmental Health (209)
  • Oncology (443)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (90)
  • Pain Medicine (35)
  • Palliative Medicine (17)
  • Pathology (130)
  • Pediatrics (196)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (782)
  • Public and Global Health (1823)
  • Radiology and Imaging (325)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)